HOME >> BIOLOGY >> NEWS
Enzyme could aid cancer fight

Scientists who have identified an enzyme which corrects gene mutations in humans say it may play a significant role in reducing people's susceptibility to serious diseases such as haemophilia, cystic fibrosis and cancer.

Teams at Cardiff University, Wales, and the University of Edinburgh, Scotland, who discovered a gene repair mechanism called the MBD4 enzyme in 1999, have now found that gene mutations are up to three times more common in mice lacking the MBD4 enzyme.

The findings of the research, led by Professor Adrian Bird of the Institute of Cell and Molecular Biology at Edinburgh and Professor Alan Clarke in the School of Biosciences at Cardiff, will be published in the journal Science on Friday 19 July.

Around 35,000 protein-coding genes are involved in the design of our bodies. All of these genes are present in every cell of the body, but not all of them are active or 'expressed' (able to build proteins). The pattern of active genes in a particular cell will determine its characteristics.

Different combinations of genes will, for example, be expressed in heart cells and liver cells, but patterns will also differ between healthy skin cells and cancerous skin cells.

Gene mutations can be caused by environmental factors such as cigarette smoke or sunlight, but, surprisingly, much gene damage is caused by the risky natural chemistry that goes on in the cells of our bodies. Genes carry the instructions for making proteins, which perform the essential processes of life, but many serious diseases like cancer are caused by accidental changes in these instructions which stop the resulting protein from doing its job properly.

The riskiest process of all is the practice of shutting down genes (so that they do not make their proteins) by marking them with chemical switches called methyl-groups. They work well for gene silencing, but in doing so they greatly increase the chances of mutation. One in three genetic changes tha
'"/>

Contact: Andrew Weltch
WeltchA@cardiff.ac.uk
44-2920-87-5596
Cardiff University
18-Jul-2002


Page: 1 2

Related biology news :

1. Enzyme maintaining chromosome ends is linked to bone cancer recurrence, decreased survival
2. Enzyme activation appears key in helping internal clock tell night from day
3. Enzyme fully degrades mad cow disease prion
4. Enzyme revealed that is key to funguss ability to breach immune system
5. Enzyme discovery sheds light on causes of rare disease, cancer
6. Enzyme could overcome industrial bleaching waste problems
7. Enzyme controls good cholesterol
8. Enzyme discovery to benefit homeland security, industry
9. Enzyme once thought harmful to Alzheimers patients now appears key to future treatment
10. Enzyme mimetic reduces tissue damage in colitis animal study
11. Enzyme studies at Brookhaven Lab may lead to new antiviral agents

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/26/2020)... ... August 24, 2020 , ... Elgia Therapeutics , a ... diseases, today announced that Dr. Stacie Canan has joined the company as its ... served as Executive Director of Global Health at Bristol Myers Squibb (formerly Celgene), ...
(Date:8/21/2020)... ... August 18, 2020 , ... ... today announced that the U.S. Food and Drug Administration (FDA) has approved the ... SBI-101, for the treatment of severe COVID-19. Approval of this IND allows Sentien ...
(Date:8/12/2020)... ... August 12, 2020 , ... Mosio recently announced its ... public health agencies of all sizes. With a focus on tracking symptoms and ... appropriate health care, Mosio helps public health departments automate communications and provide more ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... ... July 09, 2020 , ... ... Technology (MIT) has expanded the company’s exclusive license to include clinical applications ... point-of-care diagnostic market, focusing initially on the SARS-CoV-2 biosensor. CANARY’s™ fast ...
(Date:7/10/2020)... (PRWEB) , ... July 09, 2020 , ... ... to cell therapy, today announced the hiring of Allen R. Nissenson, M.D., F.A.C.P., ... and oversee the clinical development of Sentien’s lead product, SBI-101. Dr. Nissenson ...
(Date:7/7/2020)... BOSTON (PRWEB) , ... July 06, 2020 , ... ... Innovative Practices Awards. Entries from Roche, Eli Lilly, Bristol-Myers Squibb, the University of ... Since 2003, Bio-IT World has hosted an elite awards program, highlighting outstanding examples ...
(Date:7/1/2020)... ... June 29, 2020 , ... ... competitively procured purchasing contracts to its membership, recently named BioFit Engineered Products ... with the opportunity to purchase ergonomic seating, cafeteria tables, book trucks and carts ...
Breaking Biology Technology:
Cached News: